Riskier blood thinner used more often in Black patients; psychiatric
issues linked to COVID-19
Send a link to a friend
[November 13, 2020]
By Nancy Lapid
(Reuters) - The following is a roundup of
some of the latest scientific studies on the novel coronavirus and
efforts to find treatments and vaccines for COVID-19, the illness caused
by the virus.
Use of riskier blood thinner seen in Blacks with COVID-19
A new analysis of the use of blood thinners in hospitalized COVID-19
patients highlights a striking racial disparity that may help further
explain why Black patients are hit harder by the disease. The
anticoagulant enoxaparin - sold under the brand name Lovenox - which is
associated with superior COVID-19 outcomes, is more likely to be given
to Caucasian patients. Unfractionated heparin, an alternative drug
associated with more complications, is more likely to be given to Black
patients, according to data from over 25,000 hospitalized COVID-19
patients in the international Discovery VIRUS registry. Treatment with
unfractionated heparin was tied to more kidney injuries, heart injuries,
life threatening blood infections, and anemia. Black patients were 28%
more likely than Caucasians to receive heparin, the analysis found.
Mortality rates were 41% in patients who got unfractionated heparin and
15% in patients administered enoxaparin, researchers reported on Tuesday
on medRxiv ahead of peer review. Despite the availability of generic
enoxaparin, it still remains more expensive than heparin, said coauthor
Venky Soundararajan of nference, a Massachusetts data analytics company.
As the study cannot prove causality, Soundararajan's team calls for
rigorous research to elucidate the socioeconomic, racial, or other
disparities that underlie their findings.

Recovering COVID-19 patients face mental health risks
Compared to patients recovering from other medical conditions, COVID-19
survivors are at greater risk of developing mental health problems, most
commonly anxiety, depression and insomnia, psychiatrists reported on
Monday. The estimated incidence of a first psychiatric diagnosis within
90 days was 5.8% among COVID-19 survivors, compared to 2.8% in a
comparison group of flu survivors, 3.2% in patients recovering from
gallstones, and 2.5% in patients who had suffered fractures. The study,
published in The Lancet Psychiatry, included more than 62,000 U.S.
COVID-19 patients, about two-thirds of whom had never been diagnosed
with a psychiatric illness. Mental health specialists not directly
involved with the study said the findings add to growing evidence that
COVID-19 can affect the brain and mind, increasing the risk of a range
of psychiatric illnesses. "This is likely due to a combination of the
psychological stressors associated with this particular pandemic and the
physical effects of the illness," said Michael Bloomfield, a consultant
psychiatrist at University College London.
[to top of second column]
|

A 3D-printed coronavirus model is seen in front of a world map and
the words "CoronaVirus Disease (Covid-19)" on display in this
illustration taken March 25, 2020. REUTERS/Dado Ruvic/Illustration

Prone positioning might help more COVID-19 patients
Prone positioning, or lying face down, might be useful for severely
ill COVID-19 patients who can still breathe on their own, early data
suggest. Lying face down makes it easier for the lungs to deliver
oxygen to the blood. The position is often used in COVID-19 patients
on mechanical ventilators, but it is not without risks. Until the
pandemic, it was not used in patients who were not intubated, even
if they had low oxygen levels. In a report on Wednesday in CMAJ,
researchers say evidence is emerging that hospitalized COVID-19
patients who are awake and breathing on their own might benefit.
Their review of published data found that studies so far have been
small, and randomized trials are needed to clarify the benefits and
risks in COVID-19 patients, they advise. Earlier this year, Dr.
Sanja Jelic of Columbia University Medical Center told Reuters she
would not recommend prone positioning at home. "Lay people may not
be able to assess accurately whether somebody has altered mental
status or is too weak for this maneuver," she said. "Patients need
to have intact mental status and be able to turn themselves in bed
without assistance. Being in prone position while confused or
lethargic may increase the risk for aspiration and possibly worsen
already low oxygen levels."
(Reporting by Nancy Lapid and Kate Kelland; Editing by Bill Berkrot)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.

 |